← All stocks

Mineralys Therapeutics, Inc.

MLYS Net buying

CIK 0001933414 #1952 in the set updated 17 Sep 2026

Bought (120 mo)

$142.67M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$102.60M

$13.11M on a plan · $28.79M straight out of an exercise

Sold at will

$60.69M

12 of 122 sales

Net

+$40.07M

+$81.97M against sales at will

By person

14 insiders · 173 transactions

24.6×

Jon Congleton holds 24.6 times base salary in stock. $15.68M of shares against $636.50K in salary for 2025.

Salary from the company's own proxy. The shares are what Jon Congleton last reported holding, valued at $25.98, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

RA CAPITAL MANAGEMENT, L.P. entity

Director

$76.26M (6)

—

+$76.26M

5,825,521

6.59%

$151.33M

—

Slingsby Brian Taylor

Director

$7.50M (2)

$50.53M (2)

−$43.03M

7,910,038

8.95%

$205.48M

+70.8%

AKKARAJU SRINIVAS

Director

$38.10M (3)

—

+$38.10M

594,435

0.6724%

$15.44M

—

Rodman David Malcom

Chief Medical Officer

—

$19.98M (57) scheduled

−$19.98M

51,384

0.0581%

$1.33M

+674.8%

Congleton Jon

Chief Executive Officer

$105.54K (4)

$17.42M (28)

−$17.32M

603,621

0.6828%

$15.68M

−41.9%

Samsara BioCapital GP, LLC entity

10% owner

$15.60M (2)

—

+$15.60M

5,674,916

6.42%

$147.42M

+25.6%

Levy Adam Scott

CFO and Secretary

$100.00K (1)

$9.16M (23) scheduled

−$9.06M

48,538

0.0549%

$1.26M

−81.5%

HBM Healthcare Investments (Cayman) Ltd. entity

10% owner

$5.00M (1)

—

+$5.00M

3,218,106

3.64%

$83.60M

—

Warren Eric

Chief Commercial Officer

—

$3.09M (3) scheduled

−$3.09M

38,400

0.0434%

$997.51K

0.0%

Gold Alexander M

Director

—

$1.58M (5) scheduled

−$1.58M

6,200

0.0070%

$161.06K

—

Karydas Daphne

Director

—

$839.80K (4) scheduled

−$839.80K

6,200

0.0070%

$161.06K

—

Ferguson James J. III

Chief Medical Officer

—

102,400

0.1158%

$2.66M

—

SBLENDORIO GLENN

Director

—

6,200

0.0070%

$161.06K

—

DiRocco Derek

Director

—

6,200

0.0070%

$161.06K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Slingsby Brian Taylor

20 Nov 2025

Director

Sell indirect

1,000,000

$43.35

$43.35M

Congleton Jon

11 Nov 2025

Chief Executive Officer

Sell

32,850

$46.89

$1.54M

Congleton Jon

11 Nov 2025

Chief Executive Officer

Sell

112,275

$45.83

$5.15M

Congleton Jon

11 Nov 2025

Chief Executive Officer

Sell

29,207

$45.20

$1.32M

Congleton Jon

11 Nov 2025

Chief Executive Officer

Sell

4,000

$43.50

$173.98K

Congleton Jon

11 Nov 2025

Chief Executive Officer

Sell

8,862

$42.31

$374.95K

Congleton Jon

11 Nov 2025

Chief Executive Officer

Sell

12,806

$41.64

$533.24K

Levy Adam Scott

30 Jul 2025

CFO and Secretary

Sell

8,425

$15.10

$127.20K

Levy Adam Scott

30 Jul 2025

CFO and Secretary

Sell

51,500

$14.70

$757.17K

Levy Adam Scott

29 Jul 2025

CFO and Secretary

Sell

807

$14.00

$11.30K

Levy Adam Scott

28 Jul 2025

CFO and Secretary

Sell

12,946

$14.04

$181.80K

Slingsby Brian Taylor

24 Jul 2024

Director

Sell indirect

550,000

$13.05

$7.18M

Show all 173 transactions →

Mineralys Therapeutics, Inc.

By person

Individual transactions

What was left out